Skip to main content
    C

    Clover Health Investments Corp (CLOV)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $4.95
    -0.01 (-0.20%)

    Market Cap: $2.66B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Clover Health Investments Corp (CLOV) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Clover Health Investments (CLOV) trades at 123.8x trailing earnings and 1.0x sales. Its P/S of 1.0x is above its 5-year median of 0.7x. Its forward P/E is 37.7x. The median P/E across 12 similar companies is 28.4x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 228.4% higher over the next year. Its free cash flow yield is 5.0%.

    MultipleValue
    P/E (trailing)123.8x
    Forward P/E37.7x
    Price to sales1.0x
    Price to book6.7x
    EV/EBITDA185.4x
    Price to FCF19.9x
    EV/FCF17.9x
    PEGN/A
    FCF yield5.0%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/S1.0x0.7xN/A
    P/B6.7x3.0xN/A
    Medians of month-end values through Oct 2026: 57 to 60 months (5-year).

    Valuation History

    Over the 5 of the 6 year ends shown that have a P/S, its P/S ranged from 0.4x in 2023 to 1.1x in 2024.

    Year endPriceP/SP/B
    2025$2.350.6x3.9x
    2024$3.151.1x4.5x
    2023$0.950.4x1.6x
    2022$0.930.4x1.2x
    2021$3.721.1x3.3x
    2020$16.77N/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CLOV

    What is CLOV's forward P/E ratio?

    Clover Health Investments has a forward P/E ratio of 37.7x.

    Is CLOV stock overvalued?

    GNG's valuation label for CLOV is Overvalued. Its P/E of 123.8x compares with a median of 28.4x across 12 similar companies.

    What is CLOV's price to sales ratio?

    Clover Health Investments has a price to sales ratio of 1.0x.